GDS Wealth Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $344K | Sell |
4,916
-231
| -4% | -$16.1K | 0.03% | 135 |
|
|
2025
Q1 | $378K | Buy |
5,147
+174
| +3% | +$12.8K | 0.03% | 127 |
|
|
2024
Q4 | $326K | Sell |
4,973
-736
| -13% | -$48.2K | 0.03% | 135 |
|
|
2024
Q3 | $445K | Sell |
5,709
-448
| -7% | -$34.9K | 0.04% | 113 |
|
|
2024
Q2 | $480K | Sell |
6,157
-109
| -2% | -$8.5K | 0.05% | 85 |
|
|
2024
Q1 | $425K | Sell |
6,266
-97
| -2% | -$6.57K | 0.05% | 96 |
|
|
2023
Q4 | $429K | Sell |
6,363
-76
| -1% | -$5.12K | 0.06% | 94 |
|
|
2023
Q3 | $436K | Sell |
6,439
-794
| -11% | -$53.8K | 0.07% | 80 |
|
|
2023
Q2 | $518K | Sell |
7,233
-9
| -0.1% | -$644 | 0.08% | 79 |
|
|
2023
Q1 | $503K | Sell |
7,242
-125
| -2% | -$8.68K | 0.09% | 72 |
|
|
2022
Q4 | $499K | Sell |
7,367
-44
| -0.6% | -$2.98K | 0.1% | 77 |
|
|
2022
Q3 | $406K | Buy |
7,411
+44
| +0.6% | +$2.41K | 0.09% | 78 |
|
|
2022
Q2 | $487K | Sell |
7,367
-3
| -0% | -$198 | 0.11% | 74 |
|
|
2022
Q1 | $506K | Sell |
7,370
-1,562
| -17% | -$107K | 0.11% | 76 |
|
|
2021
Q4 | $520K | Buy |
+8,932
| New | +$520K | 0.12% | 75 |
|